Evidence map›Paper›PMID 23148214›Full record

ArticleThe Journal of biological chemistry2013

Depletion of the ubiquitin-binding adaptor molecule SQSTM1/p62 from macrophages harboring cftr ΔF508 mutation improves the delivery of Burkholderia cenocepacia to the autophagic machinery.

Basant A Abdulrahman, Arwa Abu Khweek, Anwari Akhter, Kyle Caution, Mia Tazi, Hoda Hassan, Yucheng Zhang, Patrick D Rowland, Sankalp Malhotra, Famke Aeffner and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Defective immunometabolism pathways in cystic fibrosis macrophages.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  13. Article
  14. Bacterial Subversion of Autophagy in Cystic Fibrosis.Frontiers in cellular and infection microbiology · 2021
    Review
  15. Review
  16. Review
  17. CFTR Modulators DampenFrontiers in cellular and infection microbiology · 2020
    Article
  18. Autophagy, Unfolded Protein Response and Lung Disease.Current research in cell biology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 4 countries.

Basant A AbdulrahmanDepartment of Microbial Infection and Immunity, Ohio State University, Columbus, Ohio 43210, USA.
Arwa Abu Khweek
Anwari Akhter
Kyle Caution
Mia Tazi
Hoda Hassan
Yucheng Zhang
Patrick D Rowland
Sankalp Malhotra
Famke Aeffner
Ian C Davis
Miguel A Valvano
Amal O Amer
The Ohio State University · USInterface (United States) · USQueen's University Belfast · GB

Funding

Translational Research in Cystic FibrosisP30DK027651 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DRUMM, MITCHELL L · 1986 to 2014
$15.6M
Role of caspases in Legionella pneumophila pulmonary infectionR01HL094586 · NHLBI · OHIO STATE UNIVERSITY · PI AMER, AMAL O · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL094586NHLBI NIH HHS R01HL094586NIDDK NIH HHS P30 DK027651
6 · The paper itself

Abstract

Cystic fibrosis is the most common inherited lethal disease in Caucasians. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), of which the cftr ΔF508 mutation is the most common. ΔF508 macrophages are intrinsically defective in autophagy because of the sequestration of essential autophagy molecules within unprocessed CFTR aggregates. Defective autophagy allows Burkholderia cenocepacia (B. cepacia) to survive and replicate in ΔF508 macrophages. Infection by B. cepacia poses a great risk to cystic fibrosis patients because it causes accelerated lung inflammation and, in some cases, a lethal necrotizing pneumonia. Autophagy is a cell survival mechanism whereby an autophagosome engulfs non-functional organelles and delivers them to the lysosome for degradation. The ubiquitin binding adaptor protein SQSTM1/p62 is required for the delivery of several ubiquitinated cargos to the autophagosome. In WT macrophages, p62 depletion and overexpression lead to increased and decreased bacterial intracellular survival, respectively. In contrast, depletion of p62 in ΔF508 macrophages results in decreased bacterial survival, whereas overexpression of p62 leads to increased B. cepacia intracellular growth. Interestingly, the depletion of p62 from ΔF508 macrophages results in the release of the autophagy molecule beclin1 (BECN1) from the mutant CFTR aggregates and allows its redistribution and recruitment to the B. cepacia vacuole, mediating the acquisition of the autophagy marker LC3 and bacterial clearance via autophagy. These data demonstrate that p62 differentially dictates the fate of B. cepacia infection in WT and ΔF508 macrophages.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAutophagyBiomarkersBurkholderia cenocepaciaBurkholderia InfectionsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGene ExpressionHeat-Shock ProteinsHumansMacrophagesMiceMice, TransgenicMicrobial ViabilityMicrotubule-Associated ProteinsAdaptor Proteins, Signal TransducingBiomarkersCystic Fibrosis Transmembrane Conductance Regulatorcystic fibrosis transmembrane conductance regulator delta F508Heat-Shock ProteinsMap1lc3b protein, mouseMicrotubule-Associated ProteinsRNA, Small InterferingSequestosome-1 ProteinSqstm1 protein, mouseUbiquitin

Identifiers

PMID23148214
PMCPMC3548511
OpenAlexW2022894714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.